Skip to main content
HairCited

ビタミンB12 栄養不足による脱毛症

F 効果 研究によると、この用途への効果は期待しにくい可能性があります。

合計8,355名の参加者を対象とした20件の研究に基づく。研究間で結果にばらつきが見られる。

<\/script>\n
`; }, get iframeSnippet() { const domain = 'haircited.com'; const params = 'ingredient\u003Dvitamin\u002Db12\u0026condition\u003Dnutritional\u002Ddeficiency\u002Dhair\u002Dloss'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

F

結論

Research shows mixed results for vitamin B12 and hair loss — while deficiency may contribute to hair thinning, supplementation is unlikely to help unless you have a confirmed B12 deficiency.

  • Mixed results across 20 studies — no consistent benefit from supplementation
  • Some studies find lower B12 levels in hair loss patients, others do not
  • No large-scale RCTs testing B12 supplementation specifically for hair regrowth
  • Supplementation may only help if a genuine B12 deficiency is present

Key Study Findings

retrospective observational n=113
Telogen Effluvium Following Coronavirus Disease-2019 Infection: A Retrospective Study of 113 Cases.
Dose: None vs: Placebo 効果: None None
Retrospective cohort n=2851
Retrospective Review of 2851 Female Patients With Telogen Effluvium: A Single-Center Experience.
Dose: None vs: Placebo 効果: Ferritin low in 46.5% of patients; iron deficiency in 29.5% p<0.05
Review
Medical Marijuana and Treatment Personalization: The Role of Genetics and Epigenetics in Response to THC …
Dose: None vs: None Outcome: None 効果: None None

対象集団: Review of pharmacogenomics of THC and CBD

Key Statistics

19

研究数

8130

参加者数

Mixed

F

グレード

Referenced Papers

Frontiers in pharmacology 2022 31 件の引用
Journal of pain … 2020 56 件の引用
American journal of … 2017 104 件の引用
Acta dermatovenerologica Croatica … 2016 6 件の引用
Prostaglandins, leukotrienes, and … 2015 40 件の引用
Dermatologic clinics 1993 38 件の引用

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

一般的な使用量

general:
2.4 mcg/day
deficiency:
1,000-2,000 mcg/day

上限量: No established UL

研究で検討された用量

用量 期間 効果 N
None -- Neutral 113
None -- Neutral 2851
None -- Mixed --
not applicable -- Mixed 180
None -- Mixed 108
None -- Positive 973
None -- Neutral --
300 mg single dose -- Mixed 9

推奨摂取タイミング: With meals; sublingual form can be taken any time

Safety & Side Effects

報告されている副作用

  • Generally well tolerated even at high doses
  • Rare allergic reactions (itching, swelling)
  • Mild diarrhea or nausea at very high doses

既知の相互作用

  • Metformin (reduces B12 absorption by 10-30%)
  • Proton pump inhibitors and H2 blockers (reduce B12 absorption)
  • Colchicine (may reduce B12 absorption)

耐容上限摂取量: No established UL

サプリメントの摂取を開始する前に、必ず医療専門家にご相談ください。

Frequently Asked Questions

Does ビタミンB12 help with 栄養不足による脱毛症?
Based on 19 studies with 8,130 participants, there is insufficient evidence at this time that ビタミンB12 may support 栄養不足による脱毛症 management. Our evidence grade is F (Evidence Against).
How much ビタミンB12 should I take for 栄養不足による脱毛症?
Studies have used various dosages. A commonly studied range is 2.4 mcg/day. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of ビタミンB12?
Reported side effects may include Generally well tolerated even at high doses, Rare allergic reactions (itching, swelling), Mild diarrhea or nausea at very high doses. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for ビタミンB12 and 栄養不足による脱毛症?
We rate the evidence as Grade F (Evidence Against). This rating is based on 19 peer-reviewed studies with 8,130 total participants. The overall direction of effect is mixed.

に関する他の成分: 栄養不足による脱毛症

ビタミンB12 他の症状・状態について

References

  1. [1] Ömer Karakoyun et al.. J Cosmet Dermatol. 2025. Retrospective Review of 2851 Female Patients With Telogen Effluvium: A Single-Center Experience. doi:10.1111/jocd.70037 PubMed
  2. [2] Małgorzata Kalak et al.. Genes (Basel). 2025. Medical Marijuana and Treatment Personalization: The Role of Genetics and Epigenetics in Response to THC and CBD. doi:10.3390/genes16121487 PubMed
  3. [3] Namrata Chhabra et al.. Int J Trichology. 2025. Telogen Effluvium Following Coronavirus Disease-2019 Infection: A Retrospective Study of 113 Cases. doi:10.4103/ijt.ijt_38_22 PubMed
  4. [4] Irem Nur Durusu Turkoglu et al.. J Cosmet Dermatol. 2024. A comprehensive investigation of biochemical status in patients with telogen effluvium: Analysis of Hb, ferritin, vitamin B12, vitamin D, thyroid … doi:10.1111/jocd.16512 PubMed
  5. [5] Leyla Bilik et al.. North Clin Istanb. 2024. Evaluation of the relationship of digital phototrichogram findings of patients with diffuse hair loss with blood TSH, ferritin and vitamin … doi:10.14744/nci.2023.33269 PubMed
  6. [6] Pieter A Cohen et al.. JAMA. 2023. Quantity of Melatonin and CBD in Melatonin Gummies Sold in the US. doi:10.1001/jama.2023.2296 PubMed
  7. [7] Hakan Arslan et al.. Dermatol Pract Concept. 2023. Micronutrient Deficiencies and Digital Computerized Phototrichogram Analysis in Telogen Effluvium: a Retrospective Correlation Study in a Tertiary Medical Center. doi:10.5826/dpc.1303a202 PubMed
  8. [8] Ayshe Sahinovic et al.. Sports Med Open. 2022. Effects of Cannabidiol on Exercise Physiology and Bioenergetics: A Randomised Controlled Pilot Trial. doi:10.1186/s40798-022-00417-y PubMed
  9. [9] Arash Salehi et al.. Front Pharmacol. 2022. Differentiating Cannabis Products: Drugs, Food, and Supplements. doi:10.3389/fphar.2022.906038 PubMed
  10. [10] Ahu Yorulmaz et al.. J Cosmet Dermatol. 2022. Telogen effluvium in daily practice: Patient characteristics, laboratory parameters, and treatment modalities of 3028 patients with telogen effluvium. doi:10.1111/jocd.14413 PubMed
  11. [11] Ümran Öner et al.. Turk J Med Sci. 2022. Nonscarring scalp alopecia: Which laboratory analysis should we perform on whom? doi:10.3906/sag-2106-28 PubMed
  12. [12] Uma Anand et al.. J Pain Res. 2020. CBD Effects on TRPV1 Signaling Pathways in Cultured DRG Neurons. doi:10.2147/JPR.S258433 PubMed
  13. [13] Kavita Poonia et al.. J Cosmet Dermatol. 2019. NonScarring Diffuse Hair Loss in Women: a Clinico-Etiological Study from tertiary care center in North-West India. doi:10.1111/jocd.12559 PubMed
  14. [14] Jordan M Thompson et al.. Am J Clin Dermatol. 2017. The Role of Micronutrients in Alopecia Areata: A Review. doi:10.1007/s40257-017-0285-x PubMed
  15. [15] Evelyn J Cheung et al.. J Drugs Dermatol. 2016. Vitamin and Mineral Deficiencies in Patients With Telogen Effluvium: A Retrospective Cross-Sectional Study. PubMed
  16. [16] Kirti Deo et al.. Dermatol Res Pract. 2016. Clinicoepidemiological Observational Study of Acquired Alopecias in Females Correlating with Anemia and Thyroid Function. doi:10.1155/2016/6279108 PubMed
  17. [17] Jana Zímová et al.. Acta Dermatovenerol Croat. 2016. Trichotillomania: Bizzare Patern of Hair Loss at 11-Year-old Girl. PubMed
  18. [18] Amrita Khaire et al.. Prostaglandins Leukot Essent Fatty Acids. 2015. Vitamin B12 and omega-3 fatty acids together regulate lipid metabolism in Wistar rats. doi:10.1016/j.plefa.2015.04.006 PubMed
  19. [19] C Durusoy et al.. Clin Exp Dermatol. 2009. The role of psychological factors and serum zinc, folate and vitamin B12 levels in the aetiology of trichodynia: a case-control … doi:10.1111/j.1365-2230.2008.03165.x PubMed
  20. [20] D H Rushton. Dermatol Clin. 1993. Management of hair loss in women. PubMed

FDAに関する免責事項: これらの記述は米国食品医薬品局(FDA)による評価を受けていません。本ウェブサイトの製品および情報は、疾病の診断、治療、治癒、または予防を目的としたものではありません。表示されているエビデンスグレードは、公開された査読済み研究の分析に基づいており、医療上の助言を構成するものではありません。サプリメントの摂取を開始する前に、必ず医療専門家にご相談ください。